Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Non-cash Items (2022 - 2024)

Immunocore Holdings (IMCR) has disclosed Non-cash Items for 3 consecutive years, with $6.2 million as the latest value for Q1 2024.

  • Quarterly Non-cash Items changed N/A to $6.2 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Mar 2024, changed N/A year-over-year, with the annual reading at $370.0 million for FY2023, 10.07% up from the prior year.
  • Non-cash Items hit $6.2 million in Q1 2024 for Immunocore Holdings, down from $370.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $370.0 million in Q4 2023 to a low of $6.2 million in Q1 2024.
  • Historically, Non-cash Items has averaged $237.4 million across 3 years, with a median of $336.1 million in 2022.
  • Biggest YoY gain for Non-cash Items was 10.07% in 2023; the steepest drop was 10.07% in 2023.
  • Year by year, Non-cash Items stood at $336.1 million in 2022, then grew by 10.07% to $370.0 million in 2023, then tumbled by 98.33% to $6.2 million in 2024.
  • Business Quant data shows Non-cash Items for IMCR at $6.2 million in Q1 2024, $370.0 million in Q4 2023, and $336.1 million in Q4 2022.